BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21054662)

  • 1. Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea.
    Paschke C; Apelt N; Fleischmann E; Perona P; Walentiny C; Löscher T; Herbinger KH
    Clin Microbiol Infect; 2011 Aug; 17(8):1194-200. PubMed ID: 21054662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: A prospective study among Finnish travellers.
    Turunen K; Antikainen J; Lääveri T; Kirveskari J; Svennerholm AM; Kantele A
    Travel Med Infect Dis; 2020; 38():101855. PubMed ID: 32846225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions.
    Lääveri T; Vilkman K; Pakkanen SH; Kirveskari J; Kantele A
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e9-908.e16. PubMed ID: 29133155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
    Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
    Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited.
    Lääveri T; Antikainen J; Pakkanen SH; Kirveskari J; Kantele A
    Clin Microbiol Infect; 2016 Jun; 22(6):535-41. PubMed ID: 26970046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High number of diarrhoeal co-infections in travellers to Benin, West Africa.
    Lääveri T; Pakkanen SH; Antikainen J; Riutta J; Mero S; Kirveskari J; Kantele A
    BMC Infect Dis; 2014 Feb; 14():81. PubMed ID: 24521079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of enterotoxigenic Escherichia coli strains isolated from Nicaraguan children in hospital, primary care and community settings.
    Vilchez S; Becker-Dreps S; Amaya E; Perez C; Paniagua M; Reyes D; Espinoza F; Weintraub A
    J Med Microbiol; 2014 May; 63(Pt 5):729-734. PubMed ID: 24554743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterotoxin-producing bacteria isolated from Swedish travellers with diarrhoea.
    Jertborn M; Svennerholm AM
    Scand J Infect Dis; 1991; 23(4):473-9. PubMed ID: 1957131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.
    Rivera FP; Ochoa TJ; Maves RC; Bernal M; Medina AM; Meza R; Barletta F; Mercado E; Ecker L; Gil AI; Hall ER; Huicho L; Lanata CF
    J Clin Microbiol; 2010 Sep; 48(9):3198-203. PubMed ID: 20631096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance profiles of diarrhoeagenic
    Boxall MD; Day MR; Greig DR; Jenkins C
    J Med Microbiol; 2020 Jul; 69(7):932-943. PubMed ID: 32530393
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
    Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
    J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diarrhoeagenic Escherichia coli in children from León, Nicaragua.
    Vilchez S; Reyes D; Paniagua M; Bucardo F; Möllby R; Weintraub A
    J Med Microbiol; 2009 May; 58(Pt 5):630-637. PubMed ID: 19369525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).
    Vidal RM; Muhsen K; Tennant SM; Svennerholm AM; Sow SO; Sur D; Zaidi AKM; Faruque ASG; Saha D; Adegbola R; Hossain MJ; Alonso PL; Breiman RF; Bassat Q; Tamboura B; Sanogo D; Onwuchekwa U; Manna B; Ramamurthy T; Kanungo S; Ahmed S; Qureshi S; Quadri F; Hossain A; Das SK; Antonio M; Mandomando I; Nhampossa T; Acácio S; Omore R; Ochieng JB; Oundo JO; Mintz ED; O'Reilly CE; Berkeley LY; Livio S; Panchalingam S; Nasrin D; Farag TH; Wu Y; Sommerfelt H; Robins-Browne RM; Del Canto F; Hazen TH; Rasko DA; Kotloff KL; Nataro JP; Levine MM
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007037. PubMed ID: 30608930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and molecular typing of enterotoxigenic Escherichia coli strains isolated from diarrheic stools in Malatya, Turkey.
    Ozerol IH; Bayraktar MR; Iseri L; Otlu B; Durmaz R
    New Microbiol; 2005 Jul; 28(3):237-43. PubMed ID: 16240696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcome of Shigella, Salmonella and Campylobacter infections in travellers returning from the tropics with fever and diarrhoea.
    Bottieau E; Clerinx J; Vlieghe E; Van Esbroeck M; Jacobs J; Van Gompel A; Van Den Ende J
    Acta Clin Belg; 2011; 66(3):191-5. PubMed ID: 21837926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
    Frech SA; Dupont HL; Bourgeois AL; McKenzie R; Belkind-Gerson J; Figueroa JF; Okhuysen PC; Guerrero NH; Martinez-Sandoval FG; Meléndez-Romero JH; Jiang ZD; Asturias EJ; Halpern J; Torres OR; Hoffman AS; Villar CP; Kassem RN; Flyer DC; Andersen BH; Kazempour K; Breisch SA; Glenn GM
    Lancet; 2008 Jun; 371(9629):2019-25. PubMed ID: 18554712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
    Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-year survey of the incidence of heat-labile enterotoxin-producing Escherichia coli and other enteric pathogens in travellers returning to the Sheffield area.
    Chapman PA; Mitchelmore DL
    Epidemiol Infect; 1988 Oct; 101(2):239-47. PubMed ID: 3053217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years.
    Lόpez-Vélez R; Lebens M; Bundy L; Barriga J; Steffen R
    Travel Med Infect Dis; 2022; 47():102293. PubMed ID: 35247581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
    Sack DA; Shimko J; Torres O; Bourgeois AL; Francia DS; Gustafsson B; Kärnell A; Nyquist I; Svennerholm AM
    Vaccine; 2007 May; 25(22):4392-400. PubMed ID: 17448578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.